ALTSTATION.IO

Mettler-Toledo International Inc. (MTD) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$1370.17

Change

-0.92%

Market Cap

$28.22B

Avg Volume

137.4K

Company Overview

Mettler-Toledo International Inc. (MTD) manufactures precision instruments and provides services to a variety of sectors, including healthcare and industrial applications. Their product lineup includes laboratory balances, liquid pipetting solutions, automated laboratory reactors, and software platforms like LabX for data management. Customers span across healthcare, life sciences, food manufacturing, retail, and academic research, relying on Mettler-Toledo’s instruments for their accuracy and reliability.

Mettler-Toledo is a market leader in precision instruments, holding a significant share in multiple segments, especially within the laboratory and industrial weighing markets. Their competitive edge comes from a strong reputation for quality, comprehensive service offerings, and an extensive distribution network. However, they face threats from challengers like Sartorius and Thermo Fisher Scientific, who are also making strides in laboratory technology and analytics, as well as the rising demand for automation in this field.

Currently, Mettler-Toledo is observing steady growth, bolstered by strong demand in the life sciences sector and consistent investment in R&D. Recent milestones include the introduction of innovative solutions that align with automation trends, aiming to enhance operational efficiency for customers. Their focus on new technologies and expanding their software capabilities indicates a strategic pivot towards integrating more advanced analytics and AI, positioning them well for future market demands.

Key Financials

Market Cap

$28.22B

Revenue

$3.94B

EBITDA

$1.20B

Gross Margin

59.7%

Profit Margin

21.2%

Revenue Growth

7.9%

Total Cash

$69.06M

Total Debt

$2.24B

Free Cash Flow

$740.55M

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

34.17

Forward P/E

27.01

Beta

1.44

52-Week High

$1525.17

52-Week Low

$946.69

EPS

$40.10

50-Day Avg

$1427.81

200-Day Avg

$1293.05

Price/Book

-112.32

Technical Analysis

Over the past 52 weeks, Mettler-Toledo International Inc. (MTD) has exhibited a generally upward trend, characterized by strength, particularly from the lows around $1,000 in late March to a peak of approximately $1,600 in December. Key support levels are observed at $1,100 and $1,300, while resistance is evident just above the recent high at around $1,375. The chart features a notable price pattern of higher lows, suggesting bullish sentiment, with the price recently consolidating around $1,370. In the last few weeks, the momentum has softened slightly, as indicated by horizontal movement near the recent resistance level of $1,373. The current price of $1,370.17 sits just below the upper bound of its 52-week range, suggesting the potential for a breakout if bullish sentiment persists or a reversal if it fails to hold above resistance. Overall, the recent performance indicates a slight pause in an otherwise strong bullish trend.

Recent News and Developments

Here are the latest news and developments for Mettler-Toledo International Inc

(MTD) stock in the past week:

1. Mettler-Toledo Exceeds Q4 2025 Earnings and Revenue Estimates

Mettler-Toledo International Inc. reported strong fourth-quarter 2025 financial results, with adjusted earnings of $13.36 per share, surpassing the Zacks Consensus Estimate of $12.76. The company’s revenue for the quarter also exceeded expectations, reaching $1.13 billion against a forecast of $1.10 billion, marking an 8.1% increase year-over-year. This performance was driven by broad-based growth across various regions and product categories, including robust sales in industrial and product inspection segments.

2. Company Issues Cautious Q1 2026 EPS Guidance Despite Strong FY2026 Outlook

While Mettler-Toledo’s Q4 2025 results were strong, the company provided a cautious outlook for the first quarter of 2026, projecting adjusted earnings per share (EPS) between $8.60 and $8.75, which falls below the market’s consensus estimate of $9.00. However, the full-year 2026 EPS guidance of $46.05 to $46.70 at the midpoint did beat analyst estimates by 1.2%. Management indicated that macro uncertainty and ongoing tariffs are expected to persist, influencing the cautious short-term outlook.

Market Sentiment and Analyst Recommendations

Bull Case

Mettler-Toledo just beat Q4 earnings by 4.7% and revenue by 2.7%, with 8.1% year-over-year growth in the quarter. Full-year 2026 guidance of $46.05-$46.70 EPS beats consensus by 1.2%, indicating management confidence despite near-term macro noise. The company is diversified across industrial inspection, laboratory, and product inspection segments, all firing on the same cylinder. New product launches like the Vero pipette and X3 X-ray solutions address real lab and manufacturing pain points, giving them pricing power in sticky markets. At 34.17 P/E against 7.9% revenue growth, you’re paying for quality and execution, not a lottery ticket. Thirteen analysts recommend buy, and the $1504.15 average target implies 9.8% upside from current levels with a realistic $1700 ceiling. The stock is trading near 52-week highs with higher lows on the chart, suggesting institutional conviction hasn’t broken.

Bear Case

Management just telegraphed Q1 2026 weakness with EPS guidance of $8.60-$8.75 versus $9.00 consensus, a 4% miss at the midpoint. They explicitly cited macro uncertainty and tariff pressures as headwinds, which means near-term margin compression is real. The balance sheet shows $2.24B debt against only $69.06M cash, a 32.5x net debt position that limits financial flexibility if business deteriorates. Insider selling of 19,565 shares worth $28 million in three months is a yellow flag on confidence at these valuations. At 34.17 P/E with only 7.9% revenue growth, you’re overpaying relative to the growth rate, and any earnings miss could trigger multiple compression. The stock is consolidating at resistance around $1373 after a $150 drop from December highs, suggesting momentum is stalling.

What to Watch

Q1 2026 earnings in April will be the real test. Management needs to deliver the $8.60-$8.75 range or better, otherwise the full-year guidance loses credibility. Watch gross margins quarter-over-quarter; tariff impact is the key variable here, and if they’re absorbing costs instead of passing them through, that’s a red flag. The $1375 resistance level is critical on the chart. A sustained break above it suggests the bull case is intact; failure to hold could signal a retest of the $1300 support. Monitor product adoption rates for the Vero pipette and X3 X-ray series in earnings commentary; these are the innovation stories that justify the premium valuation. Track insider buying activity over the next two quarters. If executives start buying again after recent selling, that’s a confidence signal worth noting. Finally, watch tariff policy developments closely, since management specifically called this out as a near-term headwind.

Analyst Consensus

BUY

Based on 13 analyst opinions

Low Target

$1200.00

Mean Target

$1504.15

High Target

$1700.00

Earnings and Financial Data

Sector

Healthcare

Industry

Diagnostics & Research

Employees

16,000

Earnings & Dividends

Next Earnings

Apr 30, 2026

EPS (Trailing)

$40.10

Dividend Yield

None

Payout Ratio

Frequently Asked Questions

Is MTD a good stock to buy?

Mettler-Toledo holds a BUY recommendation from analysts, with a target price of $1504.15. Given its strong market cap of $28.22 billion and solid growth potential in the healthcare sector, it looks attractive for investors seeking long-term gains.

What is MTD’s price target?

Analysts set Mettler-Toledo’s price target at $1504.15. This represents an upside potential of about 9.7% from its current price of $1370.17, indicating a favorable outlook.

Does MTD pay a dividend?

Mettler-Toledo does not pay a dividend. For income-focused investors, this may be a downside since the company reinvests profits for growth instead.

What is MTD’s current P/E ratio?

Mettler-Toledo has a P/E ratio of 34.17 and a forward P/E of 27.01. These figures suggest that the stock is valued on the higher side, reflecting growth expectations in the diagnostics and research industry.

What has been MTD’s stock performance in the last year?

Mettler-Toledo’s stock has traded between $946.69 and $1525.17 in the last year. This significant range indicates volatility, but the stock’s current price of $1370.17 suggests it is positioned well within that spectrum, especially with robust industry demand.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.